{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T05:05:05Z","timestamp":1766466305446,"version":"3.37.3"},"reference-count":116,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001528","name":"Wellington Medical Research Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001528","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.bbcan.2024.189123","type":"journal-article","created":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T14:08:00Z","timestamp":1716732480000},"page":"189123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Epigenetic changes associated with Bacillus Calmette-Guerin (BCG) treatment in bladder cancer"],"prefix":"10.1016","volume":"1879","author":[{"given":"Lucy C.","family":"Picard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenella J.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane N.","family":"Kenwright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron J.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2024.189123_bb0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3181\/00379727-26-4143","article-title":"On the pathological relations between cancer and tuberculosis","volume":"26","author":"Pearl","year":"1928","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.bbcan.2024.189123_bb0010","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary Bacillus Calmette-guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J. Urol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1258\/j.jmb.2007.06-15","article-title":"Albert Calmette (1863\u20131933) and Camille Gu\u00e9rin (1872\u20131961): the C and G of BCG vaccine","volume":"15","author":"Hawgood","year":"2007","journal-title":"J. Med. Biogr."},{"key":"10.1016\/j.bbcan.2024.189123_bb0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/iju.13410","article-title":"Intravesical bacillus Calmette\u2013Gu\u00e9rin instillation in non-muscle-invasive bladder cancer: a review","volume":"25","author":"Saluja","year":"2018","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110393","article-title":"Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect","volume":"129","author":"Han","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbcan.2024.189123_bb0030","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41585-018-0055-4","article-title":"Mechanisms of BCG immunotherapy and its outlook for bladder cancer","volume":"15","author":"Pettenati","year":"2018","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0035","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.amjms.2021.03.003","article-title":"Bacillus Calmette-Guerin vaccine and nonspecific immunity","volume":"361","author":"Parmar","year":"2021","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.bbcan.2024.189123_bb0040","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41585-021-00481-1","article-title":"100 years of Bacillus Calmette\u2013Gu\u00e9rin immunotherapy: from cattle to COVID-19","volume":"18","author":"Lobo","year":"2021","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0045","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.3389\/fimmu.2019.02806","article-title":"BCG-induced cross-protection and development of trained immunity: implication for vaccine design","volume":"10","author":"Covi\u00e1n","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0050","doi-asserted-by":"crossref","first-page":"14933","DOI":"10.1038\/s41598-021-94529-2","article-title":"BCG therapy is associated with long-term, durable induction of Treg signature genes by epigenetic modulation","volume":"11","author":"Keefe","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2024.189123_bb0055","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.18632\/oncotarget.1494","article-title":"1 alpha, 25-dihydroxylvitamin D3 promotes Bacillus Calmette-Gu\u00e9rin immunotherapy of bladder cancer","volume":"4","author":"Hsu","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2024.189123_bb0065","series-title":"BCG-unresponsive NMIBC: Current evidence and options","volume":"10","author":"Smelser","year":"2021"},{"key":"10.1016\/j.bbcan.2024.189123_bb0070","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/hmg\/ddac232","article-title":"Site-specific decreases in DNA methylation in replicating cells following exposure to oxidative stress","volume":"32","author":"Seddon","year":"2023","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbcan.2024.189123_bb0075","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13072-021-00388-6","article-title":"Genome-wide impact of hydrogen peroxide on maintenance DNA methylation in replicating cells","volume":"14","author":"Seddon","year":"2021","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.bbcan.2024.189123_bb0080","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","article-title":"Advances in bladder cancer biology and therapy","volume":"21","author":"Tran","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2024.189123_bb0085","doi-asserted-by":"crossref","first-page":"eaar5598","DOI":"10.1126\/sciadv.aar5598","article-title":"X chromosome protects against bladder cancer in females via a KDM6A-dependent epigenetic mechanism","volume":"4","author":"Kaneko","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbcan.2024.189123_bb0090","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1158\/1078-0432.CCR-14-0330","article-title":"Concurrent alterations in TERT, KDM6A, and the BRCA pathway in bladder cancer","volume":"20","author":"Nickerson","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189123_bb0095","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s13577-022-00789-z","article-title":"ELK1 suppresses SYTL1 expression by recruiting HDAC2 in bladder cancer progression","volume":"35","author":"Wang","year":"2022","journal-title":"Hum. Cell"},{"key":"10.1016\/j.bbcan.2024.189123_bb0100","doi-asserted-by":"crossref","first-page":"1093815","DOI":"10.1155\/2019\/1093815","article-title":"Exploring the pathological mechanism of bladder cancer based on tumor mutational burden analysis","volume":"2019","author":"Ma","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bbcan.2024.189123_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-019-0230-6","article-title":"The cancer driver genes IDH1\/2, JARID1C\/ KDM5C, and UTX\/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism","volume":"51","author":"Chang","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbcan.2024.189123_bb0110","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002707","article-title":"Novel personalized cancer vaccine platform based on Bacillus Calmette-Gu\u00e8rin","volume":"9","author":"Yl\u00f6sm\u00e4ki","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2024.189123_bb0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2024.189123_bb0120","first-page":"1954","article-title":"Epigenetic mechanisms and the hallmarks of cancer: an intimate affair","volume":"10","author":"Darwiche","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189123_bb0125","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1101\/gad.276568.115","article-title":"Role of TET enzymes in DNA methylation, development, and cancer","volume":"30","author":"Rasmussen","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2024.189123_bb0130","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/cr.2014.81","article-title":"TET-catalyzed 5-methylcytosine hydroxylation is dynamically regulated by metabolites","volume":"24","author":"Yang","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.bbcan.2024.189123_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2019.01125","article-title":"Epigenetics of bladder cancer: where biomarkers and therapeutic targets meet","volume":"10","author":"Martinez","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.bbcan.2024.189123_bb0140","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.immuni.2015.02.005","article-title":"Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization","volume":"42","author":"Jha","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2024.189123_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00194","article-title":"Epigenetic enzyme mutations: role in tumorigenesis and molecular inhibitors","volume":"9","author":"Han","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0150","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1158\/0008-5472.CAN-21-3503","article-title":"Epigenetic and transcriptional regulation of innate immunity in cancer","volume":"82","author":"Chen","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189123_bb0155","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/path.4832","article-title":"Understanding the epigenetic regulation of tumours and their microenvironments: opportunities and problems for epigenetic therapy","volume":"241","author":"Liu","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0160","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1089\/ars.2010.3492","article-title":"The redox basis of epigenetic modifications: from mechanisms to functional consequences","volume":"15","author":"Cyr","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbcan.2024.189123_bb0165","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.freeradbiomed.2016.11.038","article-title":"Oxidized C5-methyl cytosine bases in DNA: 5-Hydroxymethylcytosine; 5-formylcytosine; and 5-carboxycytosine","volume":"107","author":"Klungland","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbcan.2024.189123_bb0170","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.molcel.2015.12.014","article-title":"Serine metabolism supports the methionine cycle and DNA\/RNA methylation through de novo ATP synthesis in Cancer cells","volume":"61","author":"Maddocks","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2024.189123_bb0175","doi-asserted-by":"crossref","first-page":"2361S","DOI":"10.1093\/jn\/132.8.2361S","article-title":"Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology","volume":"132","author":"James","year":"2002","journal-title":"J. Nutr."},{"key":"10.1016\/j.bbcan.2024.189123_bb0180","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.freeradbiomed.2015.01.028","article-title":"Oxidative stress alters global histone modification and DNA methylation","volume":"82","author":"Niu","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbcan.2024.189123_bb0185","article-title":"A new trend in cancer treatment: the combination of epigenetics and immunotherapy","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0190","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/cac2.12374","article-title":"Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities","volume":"42","author":"Ge","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.bbcan.2024.189123_bb0195","first-page":"52","article-title":"New nucleophilic mechanisms of Ros-dependent epigenetic modifications: comparison of aging and cancer","volume":"5","author":"Afanas\u2019ev","year":"2023","journal-title":"Aging and disease"},{"key":"10.1016\/j.bbcan.2024.189123_bb0200","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3390\/biology3020403","article-title":"Causes and consequences of age-related changes in DNA methylation: a role for ROS?","volume":"3","author":"Rang","year":"2014","journal-title":"Biology"},{"key":"10.1016\/j.bbcan.2024.189123_bb0205","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.semradonc.2004.04.001","article-title":"Oxidative stress, redox, and the tumor microenvironment","volume":"14","author":"Cook","year":"2004","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0210","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/scrt366","article-title":"Modeling inflammation and oxidative stress in gastrointestinal disease development using novel organotypic culture systems","volume":"4","author":"Hartman","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.bbcan.2024.189123_bb0215","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8+ T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2024.189123_bb0220","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1002\/ijc.23192","article-title":"Chronic inflammation and oxidative stress in human carcinogenesis","volume":"121","author":"Federico","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2024.189123_bb0225","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3390\/cancers11040564","article-title":"Tumor-associated neutrophils in cancer: going pro","volume":"11","author":"Wu","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2024.189123_bb0230","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.4161\/cc.8.13.8985","article-title":"Chronic inflammation, the tumor microenvironment and carcinogenesis","volume":"8","author":"Gonda","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbcan.2024.189123_bb0235","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3109\/10715760903214462","article-title":"The role of hypothiocyanous acid (HOSCN) in biological systems","volume":"43","author":"Hawkins","year":"2009","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.bbcan.2024.189123_bb0240","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1093\/nar\/gki612","article-title":"5-halogenated pyrimidine lesions within a CpG sequence context mimic 5-methylcytosine by enhancing the binding of the methyl-CpG-binding domain of methyl-CpG-binding protein 2 (MeCP2)","volume":"33","author":"Valinluck","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2024.189123_bb0245","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.freeradbiomed.2004.11.006","article-title":"Chlorine transfer between glycine, taurine, and histamine: reaction rates and impact on cellular reactivity","volume":"38","author":"Peskin","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbcan.2024.189123_bb0250","doi-asserted-by":"crossref","first-page":"7839","DOI":"10.1074\/jbc.RA120.013092","article-title":"Inhibition of DNA methylation in proliferating human lymphoma cells by immune cell oxidants","volume":"295","author":"O\u2019Connor","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2024.189123_bb0255","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/15216540051080958","article-title":"Living with a killer: the effects of hypochlorous acid on mammalian cells","volume":"50","author":"Pullar","year":"2000","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bbcan.2024.189123_bb0260","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.freeradbiomed.2020.12.453","article-title":"Regulation of the epigenetic landscape by immune cell oxidants","volume":"170","author":"Das","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbcan.2024.189123_bb0265","article-title":"Bladder cancer","volume":"3","author":"Sanli","year":"2017","journal-title":"Nat. Rev. Disease Prim"},{"key":"10.1016\/j.bbcan.2024.189123_bb0270","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2217\/epi-2018-0029","article-title":"Methylomic changes in response to micronutrient supplementation and MTHFR genotype","volume":"10","author":"Stevens","year":"2018","journal-title":"Epigenomics"},{"key":"10.1016\/j.bbcan.2024.189123_bb0275","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41586-020-2682-1","article-title":"Cancer SLC43A2 alters T cell methionine metabolism and histone methylation","volume":"585","author":"Bian","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2024.189123_bb0280","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1158\/2159-8290.CD-16-0745","article-title":"Emergence of the noncoding cancer genome: a target of genetic and epigenetic alterations","volume":"6","author":"Zhou","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2024.189123_bb0285","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13148-022-01234-6","article-title":"Immune profiles and DNA methylation alterations related with non-muscle-invasive bladder cancer outcomes","volume":"14","author":"Chen","year":"2022","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.bbcan.2024.189123_bb0290","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.3390\/cells9081839","article-title":"Discovery of molecular DNA methylation-based biomarkers through genome-wide analysis of response patterns to BCG for bladder cancer","volume":"9","author":"Ilijazi","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2024.189123_bb0295","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1586\/14737159.2015.1019477","article-title":"Epigenetic biomarkers in the blood of patients with urological malignancies","volume":"15","author":"Ellinger","year":"2015","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"10.1016\/j.bbcan.2024.189123_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109202","article-title":"Therapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable to MCT4 inhibition","volume":"35","author":"Vander Linden","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2024.189123_bb0305","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/0300060513504705","article-title":"Protocadherin-17 promoter methylation in serum-derived DNA is associated with poor prognosis of bladder cancer","volume":"42","author":"Luo","year":"2014","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.bbcan.2024.189123_bb0310","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1177\/030006051204000609","article-title":"Clinical and prognostic significance of protocadherin-10 (PCDH10) promoter methylation in bladder cancer","volume":"40","author":"Lin","year":"2012","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.bbcan.2024.189123_bb0315","doi-asserted-by":"crossref","first-page":"8169","DOI":"10.1158\/0008-5472.CAN-10-1335","article-title":"Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue","volume":"70","author":"Wolff","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189123_bb0320","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2024.189123_bb0325","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/ng.907","article-title":"Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder","volume":"43","author":"Gui","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2024.189123_bb0330","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s13277-011-0310-2","article-title":"Hypermethylation in bladder cancer: biological pathways and translational applications","volume":"33","author":"S\u00e1nchez-Carbayo","year":"2012","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0335","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrurol.2013.89","article-title":"DNA methylation-based biomarkers in bladder cancer","volume":"10","author":"Kandimalla","year":"2013","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0340","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.tranon.2017.01.001","article-title":"Epigenome-wide DNA methylation profiling identifies differential methylation biomarkers in high-grade bladder cancer","volume":"10","author":"Olkhov-Mitsel","year":"2017","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0345","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jmoldx.2014.04.007","article-title":"Molecular classification of non\u2013muscle-invasive bladder cancer (pTa low-grade, pT1 low-grade, and pT1 high-grade subgroups) using methylation of tumor-suppressor genes","volume":"16","author":"Sacristan","year":"2014","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.bbcan.2024.189123_bb0350","doi-asserted-by":"crossref","first-page":"760","DOI":"10.4161\/epi.28078","article-title":"A global profile of gene promoter methylation in treatment-na\u00efve urothelial cancer","volume":"9","author":"Ibragimova","year":"2014","journal-title":"Epigenetics"},{"key":"10.1016\/j.bbcan.2024.189123_bb0355","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ctrv.2017.10.004","article-title":"The prognostic role of epigenetic dysregulation in bladder cancer: a systematic review","volume":"61","author":"Casadevall","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bbcan.2024.189123_bb0360","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/epi-2017-0156","article-title":"The diagnostic accuracy of methylation markers in urine for the detection of bladder cancer: a systematic review","volume":"10","author":"Bosschieter","year":"2018","journal-title":"Epigenomics"},{"key":"10.1016\/j.bbcan.2024.189123_bb0365","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/ijc.28121","article-title":"HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: Array-based DNA methylation and expression profiling","volume":"133","author":"Kim","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2024.189123_bb0370","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/biom6030037","article-title":"An Epigenomic approach to improving response to neoadjuvant cisplatin chemotherapy in bladder cancer","volume":"6","author":"Xylinas","year":"2016","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbcan.2024.189123_bb0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137003","article-title":"Methylation of HOXA9 and ISL1 predicts patient outcome in high-grade non-invasive bladder cancer","volume":"10","author":"Kitchen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2024.189123_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012334","article-title":"Identification of methylated genes associated with aggressive bladder cancer","volume":"5","author":"Marsit","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2024.189123_bb0385","article-title":"Bacillus Calmette\u2013Gu\u00e9rin treatment changes the tumor microenvironment of non-muscle-invasive bladder cancer","volume":"12","author":"Su","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0390","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3390\/cancers14030487","article-title":"DNA methylome changes of muscle- and neuronal-related processes precede bladder cancer invasiveness","volume":"14","author":"Bo\u0161kovi\u0107","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2024.189123_bb0395","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.bjc.6602026","article-title":"Role of urothelial cells in BCG immunotherapy for superficial bladder cancer","volume":"91","author":"Bevers","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2024.189123_bb0400","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-023-03376-9","article-title":"Tumour microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer","author":"Semeniuk-Wojta\u015b","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbcan.2024.189123_bb0405","doi-asserted-by":"crossref","first-page":"15648","DOI":"10.1038\/s41598-021-95157-6","article-title":"MyD88-dependent BCG immunotherapy reduces tumor and regulates tumor microenvironment in bladder cancer murine model","volume":"11","author":"de Queiroz","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2024.189123_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004485","article-title":"Autophagy controls BCG-induced trained immunity and the response to Intravesical BCG therapy for bladder Cancer","volume":"10","author":"Buffen","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbcan.2024.189123_bb0415","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41585-020-0346-4","article-title":"Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer","volume":"17","author":"van Puffelen","year":"2020","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0420","first-page":"581","article-title":"Tumor-infiltrating M2 macrophages driven by specific genomic alterations are associated with prognosis in bladder cancer","volume":"42","author":"Xue","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2024.189123_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108387","article-title":"BCG vaccination induces long-term functional reprogramming of human neutrophils","volume":"33","author":"Moorlag","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2024.189123_bb0430","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005518","article-title":"Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections","volume":"11","author":"van Puffelen","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2024.189123_bb0435","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.urolonc.2007.11.031","article-title":"Role of neutrophils in BCG immunotherapy for bladder cancer","volume":"26","author":"Simons","year":"2008","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0440","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clim.2019.02.005","article-title":"BCG-induced formation of neutrophil extracellular traps play an important role in bladder cancer treatment","volume":"201","author":"Liu","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0445","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1158\/1055-9965.EPI-23-0331","article-title":"Genome-scale methylation analysis identifies immune profiles and age acceleration associations with bladder cancer outcomes","volume":"32","author":"Chen","year":"2023","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.bbcan.2024.189123_bb0450","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.735590","article-title":"Optimization of BCG therapy targeting neutrophil extracellular traps, autophagy, and miRNAs in bladder cancer: implications for personalized medicine","volume":"8","author":"Mao","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.bbcan.2024.189123_bb0455","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1476-4598-13-210","article-title":"Mycobacterium bovis BCG promotes tumor cell survival from tumor necrosis factor-\u03b1-induced apoptosis","volume":"13","author":"Holla","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2024.189123_bb0460","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.coph.2018.04.007","article-title":"Trained immunity as a novel therapeutic strategy","volume":"41","author":"Mourits","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0465","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12967-023-03944-8","article-title":"BCG-induced trained immunity: history, mechanisms and potential applications","volume":"21","author":"Chen","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2024.189123_bb0470","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.793428","article-title":"Interplay among metabolism, epigenetic modifications, and gene expression in cancer","volume":"9","author":"Huo","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0475","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.1158\/0008-5472.CAN-06-1416","article-title":"Neutrophil granulocytes are required for effective Bacillus Calmette-Gu\u00e9rin immunotherapy of bladder cancer and orchestrate local immune responses","volume":"66","author":"Suttmann","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189123_bb0480","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.juro.2014.05.115","article-title":"H 2 O 2 generation by bacillus Calmette-Gu\u00e9rin induces the cellular oxidative stress response required for bacillus Calmette-Gu\u00e9rin direct effects on urothelial carcinoma biology","volume":"192","author":"Shah","year":"2014","journal-title":"J. Urol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0485","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.canlet.2014.03.014","article-title":"Secondary stimulation from Bacillus Calmette-Gu\u00e9rin induced macrophages induce nitric oxide independent cell-death in bladder cancer cells","volume":"348","author":"Thiel","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2024.189123_bb0490","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.redox.2015.08.008","article-title":"Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes","volume":"6","author":"Ryk","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0690","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bbcan.2024.189123_bb0695","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Gu\u00e9rin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"44","key":"10.1016\/j.bbcan.2024.189123_bb0700","first-page":"e1","article-title":"FASL polymorphism is associated with response to bacillus Calmette-Gu\u00e9rin immunotherapy in bladder cancer","volume":"32","author":"Lima","year":"2014","journal-title":"Urol. Oncol. Semin. Origin. Invest."},{"key":"10.1016\/j.bbcan.2024.189123_bb0705","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bbacli.2015.06.002","article-title":"Treatment of non-muscle invasive bladder cancer with Bacillus Calmette\u2013Guerin (BCG): biological markers and simulation studies","volume":"4","author":"Kiselyov","year":"2015","journal-title":"BBA Clin."},{"key":"10.1016\/j.bbcan.2024.189123_bb0710","first-page":"416","article-title":"Next generation sequencing of urine specimens: a novel platform for genomic analysis in patients with non-muscle invasive urothelial carcinoma treated with Bacillus Calmette-Guerin","volume":"125","author":"Scott","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2024.189123_bb0715","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.eururo.2017.05.032","article-title":"Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets","volume":"72","author":"Pietzak","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0515","doi-asserted-by":"crossref","first-page":"12305","DOI":"10.1038\/s41598-017-12110-2","article-title":"Anti-mycobacterial activity correlates with altered DNA methylation pattern in immune cells from BCG-vaccinated subjects","volume":"7","author":"Verma","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2024.189123_bb0720","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.eururo.2011.04.020","article-title":"Evaluation of the methylation status of tumour suppressor genes for predicting bacillus Calmette-Gu\u00e9rin response in patients with T1G3 high-risk bladder tumours","volume":"60","author":"Agundez","year":"2011","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0725","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5507\/bp.2017.008","article-title":"Methylation status as a predictor of intravesical Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy response of high grade non-muscle invasive bladder tumor","volume":"161","author":"Husek","year":"2017","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"key":"10.1016\/j.bbcan.2024.189123_bb0730","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3390\/ijms21030829","article-title":"Targeting the immune system and epigenetic landscape of urological tumors","volume":"21","author":"Lobo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2024.189123_bb0735","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.eururo.2012.05.050","article-title":"Polyamine-modulated factor-1 methylation predicts Bacillus Calmette-Gu\u00e9rin response in patients with high-grade non-muscle-invasive bladder carcinoma","volume":"63","author":"Alvarez-M\u00fagica","year":"2013","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0740","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/15592294.2019.1603963","article-title":"Identification of DNA methylation patterns predisposing for an efficient response to BCG vaccination in healthy BCG-na\u00efve subjects","volume":"14","author":"Das","year":"2019","journal-title":"Epigenetics"},{"key":"10.1016\/j.bbcan.2024.189123_bb0495","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1293212","article-title":"Characterization of a human anti-tumoral NK cell population expanded after BCG treatment of leukocytes","volume":"6","author":"Garc\u00eda-Cuesta","year":"2017","journal-title":"OncoImmunology"},{"key":"10.1016\/j.bbcan.2024.189123_bb0500","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/1097-0215(20010601)92:5<697::AID-IJC1245>3.0.CO;2-Z","article-title":"NK cells are essential for effective BCG immunotherapy","volume":"92","author":"Brandau","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2024.189123_bb0505","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3390\/ijms17030326","article-title":"Natural killer cells\u2014an epigenetic perspective of development and regulation","volume":"17","author":"Schenk","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2024.189123_bb0510","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.clim.2014.10.005","article-title":"BCG-induced trained immunity in NK cells: role for non-specific protection to infection","volume":"155","author":"Kleinnijenhuis","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0675","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1200\/JCO.22.02144","article-title":"Novel genetic subtypes of urothelial carcinoma with differential outcomes on immune checkpoint blockade","volume":"41","author":"Sarfaty","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2024.189123_bb0680","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1158\/1078-0432.CCR-14-0511","article-title":"Pharmacological biomarkers in the development of stratified cancer medicine","volume":"20","author":"Figg","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189123_bb0685","doi-asserted-by":"crossref","first-page":"500","DOI":"10.4111\/icu.20210194","article-title":"Prominence of urinary biomarkers for bladder cancer in the COVID-19 era: from the commercially available to new prospective candidates","volume":"62","author":"Piao","year":"2021","journal-title":"Invest. Clin Urol"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X24000544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X24000544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T23:11:04Z","timestamp":1737587464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X24000544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":116,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0304419X24000544"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2024.189123","relation":{},"ISSN":["0304-419X"],"issn-type":[{"type":"print","value":"0304-419X"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic changes associated with Bacillus Calmette-Guerin (BCG) treatment in bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2024.189123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189123"}}